|
Jun 13
|
United Therapeutics (UTHR) Soars 3.5%: Is Further Upside Left in the Stock?
|
|
Jun 13
|
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 to Keep Off Your Radar
|
|
Jun 11
|
Insmed Stock Jumps 29% on Encouraging PAH Study Results
|
|
Jun 10
|
Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia
|
|
Jun 10
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
May 19
|
1 Safe-and-Steady Stock on Our Buy List and 2 to Ignore
|
|
May 2
|
United Therapeutics First Quarter 2025 Earnings: Beats Expectations
|
|
May 1
|
UTHR Q1 Earnings & Revenues Beat Estimates on Higher Tyvaso Sales
|
|
May 1
|
United Therapeutics Corp (UTHR) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...
|
|
May 1
|
1 Value Stock Worth Investigating and 2 to Brush Off
|
|
May 1
|
Q1 2025 United Therapeutics Corp Earnings Call
|
|
Apr 30
|
United Therapeutics (UTHR) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
Apr 30
|
United Therapeutics (UTHR) Q1 Earnings and Revenues Top Estimates
|
|
Apr 30
|
United Therapeutics (NASDAQ:UTHR) Reports Bullish Q1
|
|
Apr 30
|
United Therapeutics: Q1 Earnings Snapshot
|
|
Apr 30
|
United Therapeutics Corporation Reports First Quarter 2025 Financial Results
|
|
Apr 29
|
United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect
|
|
Apr 28
|
Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?
|
|
Feb 14
|
United Therapeutics (UTHR): Buy, Sell, or Hold Post Q3 Earnings?
|
|
Feb 13
|
Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?
|